Before joining HGF in 2016, John worked for four years in the in-house attorney team of Rolls-Royce Plc, and for five years in private practice. Experienced in patent drafting and portfolio management, he is recognised for his high and cost-effective success rate in prosecution. He also has particular skills in clearance and opinion work, using tried and tested approaches whilst tailoring for budget, time-frame, scale and risk appetite.
John is a fully qualified Chartered and European Patent Attorney. He also holds a postgraduate degree in Management of Intellectual Property from Queen Mary University of London (which he passed with distinction) and an undergraduate degree in Physics from the University of Warwick, UK.
John is highly experienced in the field of gas turbine engine design, manufacture and operation. He has also practiced in technology fields including telecommunications, automotive components and systems, navigation systems, construction, medical devices, ablution systems, bar equipment and composites.
Having experienced a well developed mid-size in-house team and participated in the evolution of its management and administrative systems, John can assist with developing a client’s Intellectual Property management infrastructure. His in-house experience also means he is comfortable liaising with all business functions and in particular inventors and managers at all levels of seniority.
John strives to achieve an in-house department style experience for his clients, proactively working to fully understand their businesses and to improve their Intellectual Property understanding. The hallmark of this approach is the provision of clear and comprehensive advice suited to the client’s unique commercial circumstances.
Management of Intellectual Property
Managing Intellectual Property IP Stars 2021, comprising the highly recommended IP professionals, has now been published. HGF is delighted to have 14 European attorneys listed. IP STARS is the leading …Read article
Pharmaceutical and biotechnology patent applications also make top 10 most patented. Recent statistics published by the EPO show that a total of 14,295 European patent applications were filed in 2020 …Read article
The 2021 EPO Guidelines provide much needed guidance on how to protect antibodies in Europe. Biological drugs including therapeutic antibodies have become increasingly important to the pharmaceutical industry. The European …Read article
Opportunities for additional pharmaceutical product patent protection in Europe, based on the use of a drug to treat a patient exhibiting a biomarker indicative of drug response. Recent years have …Read article
Exploring the growth of patents for connected medical devices, and how best to protect them. The Internet of Things (IoT) is expected to change our lives by creating a connected …Read article
To waive, or not to waive, that is the question. The earliest identified date of a patient presenting with symptoms of a “novel coronavirus” in Wuhan, China is reported to …Read article
HGF in Europe and Knobbe Martens in the US are holding a joint webinar on 9th June. In this webinar we will explore considerations for implementing an effective strategy to …Event details
HGF Partner Dr Susan Keston and Senior Patent Attorney Dr Sofie McPherson will be presenting a webinar ‘How to capitalise on the 5G healthcare revolution’ on 25th May. This session will explore how 5G …Event details
If you would like to discuss how HGF could help you, contact one of our IP specialists.